Menu Search
Equities

Pharmacielo Ltd

PCLO:CVE

Pharmacielo Ltd

Actions
  • Price (CAD)0.115
  • Today's Change0.00 / 0.00%
  • Shares traded16.15k
  • 1 Year change-50.00%
  • Beta2.4298
Data delayed at least 15 minutes, as of Sep 20 2024 20:12 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Pharmacielo Ltd's revenues fell -70.96% from 5.31m to 1.54m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 14.52m to a larger loss of 16.30m.
Gross margin-86.39%
Net profit margin-873.57%
Operating margin-687.03%
Return on assets-61.03%
Return on equity--
Return on investment-165.82%
More ▼

Cash flow in CADView more

In 2023, cash reserves at Pharmacielo Ltd fell by 110.80k. Cash Flow from Financing totalled 4.63m or 300.20% of revenues. In addition the company used 5.15m for operations while cash from investing totalled 391.64k.
Cash flow per share-0.0761
Price/Cash flow per share--
Book value per share-0.032
Tangible book value per share-0.032
More ▼

Balance sheet in CADView more

Pharmacielo Ltd has a Debt to Total Capital ratio of 136.87%, a lower figure than the previous year's 409.70%.
Current ratio0.1378
Quick ratio0.039
Total debt/total equity--
Total debt/total capital1.37
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.